| Index | — | P/E | 5.22 | EPS (ttm) | 0.67 | Insider Own | 16.39% | Shs Outstand | 77.57M | Perf Week | -4.37% |
| Market Cap | 271.49M | Forward P/E | 10.71 | EPS next Y | 0.33 | Insider Trans | 0.67% | Shs Float | 69.28M | Perf Month | -7.16% |
| Enterprise Value | 325.49M | PEG | — | EPS next Q | 0.07 | Short Float | 8.09% | Perf Quarter | -33.84% | ||
| Income | 51.00M | P/S | 0.29 | EPS this Y | — | Short Ratio | 3.54 | Perf Half Y | -36.01% | ||
| Sales | 944.00M | P/B | 1.04 | EPS next Y | -13.27% | ROA | 13.01% | Short Interest | 5.60M | Perf YTD | 21.53% |
| Book/sh | 3.35 | P/C | 11.31 | EPS next 5Y | -2.24% | ROE | 21.15% | 52W High | 6.11 -42.72% | Perf Year | 233.33% |
| Cash/sh | 0.31 | P/FCF | 5.43 | EPS past 3/5Y | — | ROIC | 10.33% | 52W Low | 0.99 253.43% | Perf 3Y | -11.84% |
| Dividend Est. | — | EV/EBITDA | 4.28 | Sales past 3/5Y | -11.76% 0.46% | Gross Margin | 5.62% | Volatility | 3.35% 3.45% | Perf 5Y | -38.92% |
| Dividend TTM | — | EV/Sales | 0.34 | EPS Y/Y TTM | — | Oper. Margin | 3.85% | ATR (14) | 0.14 | Perf 10Y | -53.02% |
| Dividend Ex-Date | — | Quick Ratio | 2.17 | Sales Y/Y TTM | 1.18% | Profit Margin | 5.48% | RSI (14) | 37.48 | Recom | 2.00 |
| Dividend Gr. 3/5Y | — | Current Ratio | 3.19 | EPS Q/Q | 200.00% | SMA20 | -3.82% | Beta | 0.12 | Target Price | 10.00 |
| Payout | 2.45% | Debt/Eq | 0.30 | Sales Q/Q | 12.84% | SMA50 | -8.18% | Rel Volume | 0.65 | Prev Close | 3.65 |
| Employees | 390 | LT Debt/Eq | 0.30 | Earnings | Nov 04 | SMA200 | -18.34% | Avg Volume | 1.34M | Price | 3.50 |
| IPO Date | Mar 24, 2005 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 78.89% 6.25% | Net Debt/EBITDA | 0.71 | Volume | 865,367 | Change | -4.11% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Aug-06-26 | Reiterated | Scotiabank | $10 | |
| May-07-26 | Reiterated | HC Wainwright & Co. | Buy | $10 |
| May-07-24 | Reiterated | Craig-Hallum | Buy | $3.50 |
Alto Ingredients, Inc., operating within the United States, specializes in the production and commercialization of both specialty alcohols and various essential ingredients. Its operations are structured into three distinct segments: Marketing and Distribution, Pekin Production, and Other Production. The company's diverse product portfolio includes a range of specialty alcohols, which find applications across the health, home, and beauty sectors. These alcohols are key components in products such as mouthwash, cosmetics, pharmaceuticals, hand sanitizers, disinfectants, and various cleaning solutions. Additionally, Alto Ingredients supplies grain neutral spirits, vital for alcoholic beverages, flavor extracts, and vinegar production. It also provides corn germ for corn oil manufacturing and carbon dioxide, primarily serving the food and beverage industries. Its essential ingredients segment encompasses a variety of products critical for commercial animal feed and pet food formulations, including dried yeast, corn gluten meal, corn gluten feed, distillers grains, and liquid feed. Furthermore, the company is a supplier of fuel-grade ethanol, primarily utilized as a transportation fuel, and distillers corn oil, which serves as a feedstock for biodiesel production. Notably, some of the fuel-grade ethanol it offers is sourced from third-party producers. Beyond manufacturing, Alto Ingredients facilitates transportation, storage, and delivery services for its products, leveraging a network of third-party service providers. Its diverse customer base includes integrated oil companies and gasoline marketers for its ethanol products; dairies and feedlots for essential ingredient feedstuffs; and poultry and biodiesel manufacturers for its corn oil. The company boasts five alcohol production facilities: three strategically located in the Midwestern state of Illinois, and two further west in Oregon and Idaho. Headquartered in Pekin, Illinois, Alto Ingredients, Inc. was established in 2003. The company underwent a significant rebranding in January 2021, changing its name from its former identity, Pacific Ethanol, Inc.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 944 | 918 | 965 | 1,223 | — | — | — | — | — | |
| Cost of Goods Sold Incl. D&A | 891 | 891 | 956 | 1,207 | — | — | — | — | — | |
| Gross Profit | 53 | 27 | 10 | 16 | — | — | — | — | — | |
| Selling, General and Administrative Excl. Other | 29 | 27 | 30 | 33 | — | — | — | — | — | |
| Research and Development | 0 | 0 | 0 | 0 | — | — | — | — | — | |
| Other Operating Expense | -12 | -7 | 31 | 7 | — | — | — | — | — | |
| Operating Income | 37 | 7 | -52 | -24 | — | — | — | — | — | |
| Interest Expense | 9 | 11 | 8 | 7 | — | — | — | — | — | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 25 | 16 | 1 | 3 | — | — | — | — | — | |
| Net Income Before Taxes | 51 | 13 | -59 | -28 | — | — | — | — | — | |
| Income Taxes | -1 | -1 | 0 | 0 | — | — | — | — | — | |
| Consolidated Net Income | 51 | 13 | -59 | -28 | — | — | — | — | — | |
| Net Income From Continuing Operations | 52 | 13 | -59 | -28 | — | — | — | — | — | |
| Net Income | 51 | 13 | -59 | -28 | — | — | — | — | — | |
| EPS (Recurring) | 0.68 | 0.16 | -0.82 | -0.40 | — | — | — | — | — | |
| EPS (Basic, Before Extraordinaries) | 0.68 | 0.16 | -0.82 | -0.40 | — | — | — | — | — | |
| EPS (Diluted) | 0.67 | 0.16 | -0.82 | -0.40 | — | — | — | — | — | |
| EBITDA | 76 | 49 | -27 | 3 | — | — | — | — | — | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 5.22 | 18.00 | — | — | — | — | — | — | — | |
| Price To Sales Ratio | 0.28 | 0.24 | 0.12 | 0.16 | — | — | — | — | — | |
| Gross Margin | 5.61 | 2.94 | 1.04 | 1.31 | — | — | — | — | — | |
| Operating Margin | 3.92 | 0.76 | -5.39 | -1.96 | — | — | — | — | — | |
| Net Margin | 5.40 | 1.42 | -6.11 | -2.29 | — | — | — | — | — | |
| Shares Outstanding | 76 | 75 | 73 | 73 | — | — | — | — | — | |
| Market Capitalization | 266 | 216 | 114 | 194 | — | — | — | — | — | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| NATHAN GILBERT E | Director | Sep 14 '26 | Buy | 3.93 | 10,000 | 39,299 | 866,393 | Sep 14 |
| NATHAN GILBERT E | Director | Aug 11 '26 | Buy | 4.15 | 50,000 | 207,500 | 856,393 | Aug 12 |
| NATHAN GILBERT E | Director | May 13 '26 | Buy | 4.45 | 5,000 | 22,250 | 774,741 | May 14 |
| NATHAN GILBERT E | Director | May 12 '26 | Buy | 4.61 | 20,000 | 92,200 | 769,741 | May 14 |
| Sneed James R | Chief Commercial Officer | Aug 13 '25 | Buy | 1.06 | 3,176 | 3,364 | 432,397 | Aug 14 |
| NATHAN GILBERT E | Director | Nov 13 '24 | Buy | 1.34 | 30,000 | 40,100 | 700,575 | Nov 15 |
| McGregor Bryon T | President & CEO | Nov 12 '24 | Buy | 1.36 | 37,000 | 50,424 | 834,265 | Nov 13 |
| Olander Robert R. | Chief Financial Officer | Nov 12 '24 | Buy | 1.35 | 7,350 | 9,959 | 225,056 | Nov 13 |
| NATHAN GILBERT E | Director | Jun 01 '23 | Buy | 1.97 | 5,000 | 9,850 | 583,909 | Jun 02 |
| NATHAN GILBERT E | Director | May 31 '23 | Buy | 1.99 | 5,000 | 9,950 | 578,909 | Jun 02 |
| NATHAN GILBERT E | Director | Mar 17 '23 | Buy | 1.71 | 10,000 | 17,100 | 573,909 | Mar 20 |
| NATHAN GILBERT E | Director | Mar 16 '23 | Buy | 1.81 | 10,000 | 18,100 | 563,909 | Mar 17 |
| NATHAN GILBERT E | Director | Mar 15 '23 | Buy | 1.86 | 15,000 | 27,900 | 553,909 | Mar 17 |
| Graham Auste M | Gen. Counsel, VP & Secy | Mar 16 '23 | Buy | 1.85 | 2,700 | 4,995 | 65,935 | Mar 16 |
| Graham Auste M | Gen. Counsel, VP & Secy | Mar 14 '23 | Buy | 1.98 | 2,526 | 5,001 | 63,235 | Mar 16 |